Nexa3D Acquires Addifab, Launches Digital Tooling for Injection Molding
Nexa3D , the ultrafast polymer 3D printing leader, announced today that it completed the acquisition of Addifab, the originator of Freeform Injection Molding, a proprietary and patented digital tooling process that couples the design freedom of 3D printing with the mechanical performance of injection molding using thousands of tried-and-true engineering materials.
- Nexa3D , the ultrafast polymer 3D printing leader, announced today that it completed the acquisition of Addifab, the originator of Freeform Injection Molding, a proprietary and patented digital tooling process that couples the design freedom of 3D printing with the mechanical performance of injection molding using thousands of tried-and-true engineering materials.
- The joint sales and marketing efforts resulted in converting dozens of customers from traditional tooling to digital tooling due to significant time and cost savings associated with this innovative approach.
- The combination of these two highly complementary technologies unlocks the full potential of digital tooling for injection molding combining the freedom of creation with the reliability and ubiquity of injection molding, uniquely positioning Nexa3D for accelerated growth in the fast-growing additive manufacturing space.
- Located in Copenhagen, Denmark, Addifab developed, patented, and successfully brought to market a proprietary end-to-end digital tooling solution that includes CAD-to-Tool software generator, dissolvable tooling resins, 3D printing and production injection molding process.